BRUCE I. SACHS - 01 May 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Director
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
01 May 2022
Net transactions value
$0
Form type
4
Filing time
03 May 2022, 16:43:02 UTC
Previous filing
18 Apr 2022
Next filing
19 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRTX Stock Option (Right to Buy) Award $0 +4,462 $0.000000 4,462 01 May 2022 Common Stock 4,462 $276.17 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.